Paradoxical results in the study of risk factors of chronic obstructive pulmonary disease (COPD) re-admission

Respiratory Medicine

Volumn 98, Issue 9, 2004, Pages 851-857

  Garcia Aymerich, Judith ^a   Marrades, Ramon M ^b   Eduard, Monsó ^c   Barreiro, Esther ^d   Farrero, Eva ^e   Antó, Josep M ^a,f   Sunyer, Jordi ^a   Alonso, Jordi ^a   Félez, Miguel A ^d   Escarrabill, Joan ^e   Redondo, Ma Jose ^e   Soler, Nestor ^b   Torres, Antoni ^b   Bonet, Gloria ^c   Izquierdo, Jose ^c   Morera, Joseph ^c  

^a INST MUNIC D INVESTIGACIO MEDICA   (Spain)

^b HOSPITAL CLÍNIC   (Spain)

^c HOSPITAL UNIVERSITARI GERMANS TRIAS I PUJOL   (Spain)

^d HOSPITAL DEL MAR   (Spain)

^e Universitaria de Bellvitge ^*  (Spain)

^f UNIVERSITAT POMPEU FABRA   (Spain)

Author keywords

Confounding by indication; Confounding by severity; COPD; Paradoxical results

Indexed keywords

CHOLINERGIC RECEPTOR BLOCKING AGENT; CORTICOSTEROID; INFLUENZA VACCINE; IPRATROPIUM BROMIDE; OXYGEN;

ARTERIAL OXYGEN TENSION; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; COHORT ANALYSIS; DISEASE SEVERITY; DRUG USE; FOLLOW UP; FORCED EXPIRATORY VOLUME; HOSPITAL ADMISSION; HOSPITALIZATION; HUMAN; IMMUNE DEFICIENCY; LONG TERM CARE; MEDICAL CARE; MYOPATHY; OXYGEN THERAPY; PRIORITY JOURNAL; RISK FACTOR; SPAIN; STATISTICAL ANALYSIS; TACHYCARDIA;

ADRENAL CORTEX HORMONES; CHOLINERGIC ANTAGONISTS; FORCED EXPIRATORY VOLUME; HUMANS; OXYGEN; OXYGEN INHALATION THERAPY; PATIENT READMISSION; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RISK FACTORS; SEVERITY OF ILLNESS INDEX;

EID: 4043076400     PISSN: 09546111     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rmed.2004.02.019     Document Type: Article

References (27)

1. Garcia-Aymerich J. Monsó E. Marrades R.M. et al. Risk factors for hospitalisation for a chronic obstructive pulmonary disease exacerbation. EFRAM study Am J Respir Crit Care Med 164 2001 1002-1007
2. Anthonisen N.R. Wright E.C. Hodgkin J.E. IPPB Trial Group. Prognosis in chronic obstructive pulmonary disease Am Rev Respir Dis 133 1986 14-20
3. Pelkonen M. Tukiainen H. Tervahauta M. et al. Pulmonary function, smoking cessation and 30 year mortality in middle aged Finnish men Thorax 55 2000 746-750
4. Schols A.M.W.J. Wesseling G. Kester A.D.M. et al. Dose dependent increased mortality risk in COPD patients treated with oral glucocorticoids Eur Respir J 17 2001 337-342
5. Garcia-Aymerich J. Farrero E. Félez M.A. et al. Risk factors of re-hospitalisation for a COPD exacerbation: a prospective study Thorax 58 2003 100-105
6. Anthonisen N.R. Smoking, lung function, and mortality Thorax 55 2000 729-734
7. Siafakas N.M. Vermeire P. Pride N.B. et al. Optimal assessment and management of chronic obstructive pulmonary disease (COPD) Eur Respir J 8 1995 1398-1420
8. Anthonisen N.R. Manfreda J. Warren C.P.W. et al. Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease Ann Intern Med 106 1987 196-204
9. Garcia-Aymerich J. Barreiro E. Farrero E. et al. Patients hospitalized for COPD have a high prevalence of modifiable risk factors for exacerbation (EFRAM study) Eur Respir J 16 2000 1037-1042
10. Szklo M. Nieto J. Epidemiology beyond the basics 2000 Aspen Publishers, Inc. Gaithersburg
11. Stürmer T. Glynn R.J. Kliebsch U. Brenner H. Analytic strategies for recurrent events in epidemiologic studies: background and application to hospitalisation risk in the elderly J Clin Epidemiol 53 2000 57-64
12. Salas M. Hofman A. Stricker B.H. Confounding by indication: an example of variation in the use of epidemiologic terminology Am J Epidemiol 149 1999 981-983
13. Psaty B.M. Koepsell T.D. Lin D. et al. Assessment and control for confounding by indication in observational studies J Am Geriatr Soc 47 1999 749-754
14. Kessler R. Faller M. Fourgaut G. Mennecier B. Weitzenblum E. Predictive factors of hospitalisation for acute exacerbation in a series of 64 patients with chronic obstructive pulmonary disease Am J Respir Crit Care Med 159 1999 158-164
15. Weitzenblum E. Demets M. Treatment of pulmonary hypertension in chronic obstructive pulmonary disease. In: Postma DS, Siafakas NM. Management of chronic obstructive pulmonary disease. European Respiratory Monograph 7. Sheffield: European Respiratory Society; 1998.
16. 1 decline and chronic obstructive pulmonary disease morbidity Am J Respir Crit Care Med 153 1996 1530-1535
17. Decramer M. Gosselink R. Troosters T. Verschueren M. Evers G. Muscle weakness is related to utilization of health care resources in COPD patients Eur Respir J 10 1997 417-423
18. Greenland S. Confounding and exposure trends in case-crossover and case-time-control designs Epidemiology 7 1996 231-239
19. Suissa S. The case-time-control design: further assumptions and conditions Epidemiology 9 1998 441-445
20. Robins J.M. Blevins D. Ritter G. Wulfsohn M. G-estimation of the effect of prophylaxis therapy for pneumocistis carinii pneumonia on the survival of AIDS patients Epidemiology 3 1992 319-336
21. Hernán M.A. Brumback B. Robins J.M. Marginal structural models to estimate the causal effect of zidovudine on the survival of HIV-positive men Epidemiology 11 2000 561-570
22. Johnston S.C. Combining ecological and individual variables to reduce confounding by indication: case study-subarachnoid hemorrhage treatment J Clin Epidemiol 53 2000 1236-1241
23. Hox J. Maas C.J.M. Sample sizes for multilevel modelling In: Blasius J. Hox J. de Leeuw E. Schmidt P. editors. Social Science Methodology in the New Millennium. Proceedings of the Fifth International Conference on Logic and Methodology. Second expanded edition 2002 Leske+Budrich Verlag (CD-ROM) Opladen, RG
24. Guite H.F. Dundas R. Burney P.G.J. Risk factors for death from asthma, chronic obstructive pulmonary disease, and cardiovascular disease after a hospital admission for asthma Thorax 54 1999 301-307
25. Sin D.D. Tu J.V. Lack of association between ipratropium bromide and mortality in elderly patients with chronic obstructive airway disease Thorax 55 2000 194-197
26. Anthonisen N.R. Connett J.E. Enright P.L. Manfreda J. And the Lung Health Study Research. Group Hospitalizations and mortality in the Lung Health Study Am J Respir Crit Care Med 166 2002 333-339
27. Laupacis A. Wells G. Richardson W.S. Tugwell P. User's guides to the medical literature: V. How to use an article about prognosis JAMA 272 1994 234-237